We've established a 'Sandbox' model for the adaptive development and deployment of various technologies to bring affordable therapeutics to the global market. We achieve this through strategic partnerships with the biotechnology industry and the creation of new product-based spin-offs.

​

Altus offers approximately 10,000 sq. ft. of space with modular capabilities for cell culture, protein production, analytics, robotics-guided automated screening, and a data science platform. This setup allows for seamless iterations between building computational models, including AI and ML, and experimental data.

​

Our team benefits from the guidance of seasoned experts with a track record of building successful companies. We employ an innovative design space that integrates ML/AI, analytical technologies, and a robust regulatory science-based framework to develop therapeutics with a focus on clinical differentiation from standard-of-care.